SearchPublisher and Institutes
You are here: Home :: Area NEM :: Medical science :: Human medicine
Rmi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, Gerald Kierzek, David Sebaoun, Zohar Mishal, Jean-Pierre Vannier, Jeanne Yvonne Borg, Guy Simoneau, Claudine Soria, Jeannette Soria
Clot structure modification by fondaparinux and consequence on fibrinolysis: A new mechanism of antithrombotic activity
Keywords: Fondaparinux, clot structure, fibrinolysis, fibrin network
Fondaparinux is a synthetic pentasaccharide consisting of the minimal sequence of heparin which interacts with antithrombin (AT). It represents a new class of selective factor Xa inhibitors without any antithrombin activity. It has been shown to exhibit potent antithrombotic properties in clinical studies. However, the mechanism of its antithrombotic action has not yet been fully established. In the present study it was shown that fondaparinux, used at pharmacological concentration (500 ng/ml), rendered the clot more susceptible to fibrinolysis induced by t-PA: plasma fibrin clots formed in the presence of fondaparinux and perfused with t-PA were degraded at a faster rate than those formed in the absence of fondaparinux. This fibrinolytic activity of fondaparinux is mainly due to a modification of clot structure characterized by a loose fibrin conformation with less branched fibers and the presence of large pores in comparison to control clots which present a tighter conformation. The difference in fibrin structure was responsible for an increase in clot porosity leading to a better availability of t-PA to the fibrin network. It is related to the decrease in thrombin generation, in an AT-dependent pathway. It was also demonstrated that in the presence of exogenous thrombomodulin, the inhibition of TAFI activation by fondaparinux could contribute, to a lesser extent, to the increased thrombus lysis. The increase in t-PA induced thrombus lysis could contribute to the antithrombotic activity of fondaparinux.
Thrombosis and Haemostasis, Schattauer
Print ISSN: 0340-6245
Volume: 97, 01/2007
Pages: 27 - 31